99%+ Purity Guarantee

Undergoes independent third-party verification before release. Tested to confirm ≥99% purity.

Buy Tirzepatide 10mg Online

Name: Tirzepatide 10mg
Brand: NOVERA COMPOUNDS
SKU: 100265
Price: 171 USD
Availability: InStock

Tirzepatide is a synthetic dual-agonist peptide studied for its activity at GLP-1 and GIP receptors. Research suggests that it may influence glucose regulation, appetite signaling, and energy metabolism, primarily through incretin-mediated endocrine pathways.

$171.00

General info

Brand	NOVERA COMPOUNDS
Strength	10mg
CAS	2023788-19-2
Chemical Formula	C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight	4813.48 g/mol
Peptide Sequence	Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Synonyms	P1206, LY3298176, tirzepatida, tirzepatidum, OYN3CCI6QE
Storage	Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.

Disclaimer: Sold as a research-grade lyophilized peptide in dry powder form. Requires reconstitution under controlled laboratory conditions. Reconstitution agents are not included.

For Research Use Only (RUO): Not for human or animal use, consumption, injection, or application. Not for diagnostic, therapeutic, or clinical purposes.

Buy More Peptides for Research Buy More Weight Loss & Metabolic Peptides Products

Free Shipping Over $1000

With fast order dispatch

Guaranteed Product Authenticity

All products contain original LOT numbers

Secure SSL
Encryption

Your data is safe with us

No Order
Minimum

Get the exact quantity you need.

Why Novera Compounds?

Precision-Synthesized Peptides

Advanced synthesis techniques ensure high structural fidelity and ≥99% purity.

Third-Party Verified Quality:

Independent laboratories confirm identity, purity, and batch consistency.

Research-Grade Reliability:

Designed for reproducible laboratory and analytical applications.

Strict Regulatory Compliance:

Products meet Research Use Only (RUO) standards and relevant laboratory regulations.

Documented Transparency:

Certificates of Analysis and quality verification reports provided for every lot.

555a76c773c8ed79615174887299fb4c5c66d2ad

Tirzepatide 10mg – About This Product

Tirzepatide 10mg is a synthetic 39–amino acid peptidedeveloped for advanced metabolic and endocrine research. It is engineered as a tirzepatide dual agonist, meaning it has been designed to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) biological systems.

The peptide sequence is based on native GIPand includes specific structural modifications intended to enhance molecular stabilityand extend circulation time in research models. These modifications include the incorporation of aminoisobutyric acid (Aib) residues and conjugation of a C20 fatty diacid to a lysine residue via a hydrophilic linker, which increases albumin binding.

Tirzepatide peptide has a molecular weight of approximately 4810.5 g/mol and is supplied as a lyophilized white to off-white powder with ≥98% purity, verified by analytical testing such as HPLC/MS. The 10mg vial format is commonly used in dose-escalation and mid-to-higher dose research protocols investigating metabolic regulation, energy balance, and gastrointestinal signaling.

Tirzepatide 10mg – Key Features and Benefits

Research-grade purity of ≥98%, verified by HPLC/MS for consistency and reproducibility

Supplied as a lyophilized powder in sealed vials for controlled laboratory handling

Designed for studies exploring combined incretin signaling, including investigators who buy tirzepatide for non-clinical research use

Structural modifications support extended stability and prolonged biological exposure in experimental models

Suitable for mid-range and advanced dose-escalation studies using the tirzepatide 10 mg peptide format

Used in research examining metabolic, gastrointestinal, and neuroendocrine systems

Stable under recommended refrigerated storage conditions when handled correctly

For laboratory research use only, clearly labeled for compliant, non-therapeutic use

Those who plan to buy tirzepatide for research often select this format for controlled metabolic and receptor-based investigations.

Tirzepatide 10mg – Mechanism & Research Applications

Tirzepatide has been investigated as a single-molecule dual incretin agonist, producing broader metabolic effects than agents targeting only one incretin pathway. In research settings, studies examining tirzepatide for research have focused on the following areas:

Glucose Regulation: Studied for its role in enhancing glucose-dependent insulin secretion and moderating glucagon release in experimental models

Energy Balance and Appetite: Investigated for effects on central and peripheral signaling involved in satiety, caloric intake, and energy expenditure

Lipid Handling: Evaluated for dose-dependent effects on postprandial lipid metabolism and adipose tissue signaling

Gastrointestinal Function: Examined for its influence on gastric emptying rates and nutrient absorption timing

Metabolic Flexibility: Explored for its ability to influence substrate utilization and overall energy homeostasis

These applications reflect controlled laboratory and clinical research investigations and do not represent approved therapeutic use.

Tirzepatide 10mg – Dosing & Observed Effects in Research

In research contexts, tirzepatide has been evaluated using structured dose-escalation protocols to characterize pharmacokinetics and biological response patterns. In human clinical research programs, dosing commonly begins at 2.5 mg once weeklyand increases in 2.5 mg increments every four weeks. The 10mg dose represents an intermediate-to-higher level within this escalation framework and is frequently used to assess dose–response relationships.

Furthermore, published clinical trial programs, including large-scale metabolic studies, report that tirzepatide 10mg is associated with measurable, dose-dependent changesin glucose handling, insulin secretion dynamics, lipid parameters, and appetite-related biomarkers.

Pharmacokinetic data indicate a time to peak concentrationranging from approximately 8 to 72 hoursfollowing subcutaneous administration, with an estimated half-life of around five days, supporting once-weekly dosing in research protocols.

Additionally, gastrointestinal observations, such as nausea or delayed gastric emptying, have been reported more frequently at higher doses, including 10mg, within controlled research settings.

Tirzepatide 10mg – Storage, Safety & References

Unreconstituted: Tirzepatide 10mg should be stored as a lyophilized powder in its original sealed vial at 2–8°C, protected from light and moisture to maintain stability. Refrigerated storage is recommended prior to reconstitution, and prolonged room-temperature storage is not advised.
Reconstituted: Once reconstituted using sterile diluent, solutions should be kept refrigerated at 2–8°C and used within the timeframe specified by the research protocol, typically within 28–30 days. Avoid freeze-thaw cycles, as they can degrade the peptide’s quality.
Reconstitution: Reconstitution should be performed using aseptic technique with sterile equipment. The vial should be gently swirled rather than shaken to avoid peptide aggregation.
Aseptic handling: Standard laboratory personal protective equipment, including gloves, eye protection, and a lab coat, should be used during handling

All unused material and waste should be disposed of in accordance with institutional biosafety procedures and local regulations. Always consult the provided Safety Data Sheet (SDS) for detailed handling, hazard, and disposal guidance.